S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Zhongchao (ZCMD) Competitors

$1.94
+0.49 (+33.79%)
(As of 04/19/2024 ET)

ZCMD vs. GMDAQ, NH, SNOA, NOVN, NIVF, AGRX, CYTO, QNRX, EIGR, and DYNT

Should you be buying Zhongchao stock or one of its competitors? The main competitors of Zhongchao include Gamida Cell (GMDAQ), NantHealth (NH), Sonoma Pharmaceuticals (SNOA), Novan (NOVN), NewGenIvf Group (NIVF), Agile Therapeutics (AGRX), Altamira Therapeutics (CYTO), Quoin Pharmaceuticals (QNRX), Eiger BioPharmaceuticals (EIGR), and Dynatronics (DYNT). These companies are all part of the "medical" sector.

Zhongchao vs.

Zhongchao (NASDAQ:ZCMD) and Gamida Cell (NASDAQ:GMDAQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Company Net Margins Return on Equity Return on Assets
ZhongchaoN/A N/A N/A
Gamida Cell N/A N/A -57.59%

Zhongchao has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, Gamida Cell has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.

1.7% of Zhongchao shares are owned by institutional investors. Comparatively, 50.3% of Gamida Cell shares are owned by institutional investors. 28.6% of Zhongchao shares are owned by insiders. Comparatively, 6.7% of Gamida Cell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Zhongchao has higher revenue and earnings than Gamida Cell.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zhongchao$14.15M0.26-$2.94MN/AN/A
Gamida Cell$1.78M1.50-$63M-$0.63-0.03

In the previous week, Zhongchao had 2 more articles in the media than Gamida Cell. MarketBeat recorded 2 mentions for Zhongchao and 0 mentions for Gamida Cell. Zhongchao's average media sentiment score of 0.59 beat Gamida Cell's score of 0.00 indicating that Zhongchao is being referred to more favorably in the media.

Company Overall Sentiment
Zhongchao Positive
Gamida Cell Neutral

Zhongchao and Gamida Cell both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
ZhongchaoN/AN/A
Gamida CellN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zhongchao
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Gamida Cell
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Zhongchao beats Gamida Cell on 6 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZCMD vs. The Competition

MetricZhongchaoEducational services IndustryMedical SectorNASDAQ Exchange
Market Cap$3.73M$922.65M$4.79B$7.30B
Dividend YieldN/A2.01%2.93%4.01%
P/E RatioN/A7.22235.9718.06
Price / Sales0.261.742,475.5089.22
Price / CashN/A12.8447.0734.82
Price / Book0.112.274.554.16
Net Income-$2.94M$23.22M$103.85M$214.28M
7 Day Performance18.29%-2.52%-4.50%-3.54%
1 Month Performance23.57%-6.48%-6.07%-4.09%
1 Year Performance-84.23%-0.20%6.72%3.30%

Zhongchao Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMDAQ
Gamida Cell
0 of 5 stars
$0.02
flat
N/AN/A$2.62M$1.78M-0.03N/AGap Down
NH
NantHealth
0 of 5 stars
$0.34
flat
N/A-76.5%$2.63M$67.68M-0.04326Analyst Report
SNOA
Sonoma Pharmaceuticals
2.1621 of 5 stars
$0.17
flat
$3.25
+1,857.8%
-84.0%$2.59M$13.27M-0.179Positive News
NOVN
Novan
0 of 5 stars
$0.00
flat
N/AN/A$2.64M$24.71M0.0090
NIVF
NewGenIvf Group
0 of 5 stars
$0.69
-15.8%
N/AN/A$2.58MN/A0.00N/AGap Down
AGRX
Agile Therapeutics
2.2877 of 5 stars
$0.39
+5.5%
$8.50
+2,104.5%
-94.7%$2.65M$19.59M-0.0422
CYTO
Altamira Therapeutics
0 of 5 stars
$1.63
-1.8%
N/A-93.7%$2.58M$320,000.000.0010
QNRX
Quoin Pharmaceuticals
2.459 of 5 stars
$0.72
+1.4%
$4.00
+455.6%
-87.5%$2.66MN/A-0.074News Coverage
Positive News
Gap Up
EIGR
Eiger BioPharmaceuticals
3.8261 of 5 stars
$1.73
-9.2%
$120.00
+6,856.5%
N/A$2.55M$15.77M-0.0356Analyst Report
DYNT
Dynatronics
1.8586 of 5 stars
$0.55
+48.6%
$3.80
+590.9%
-60.6%$2.68M$40.61M-0.40154Analyst Report
Gap Up
High Trading Volume

Related Companies and Tools

This page (NASDAQ:ZCMD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners